Evidence map›Paper›PMID 34922465›Full record

ArticleBMC medical research methodology2021

Modelling of longitudinal data to predict cardiovascular disease risk: a methodological review.

David Stevens, Deirdre A Lane, Stephanie L Harrison, Gregory Y H Lip, Ruwanthi Kolamunnage-Dona

Abstract read
In one paragraph

Article in BMC medical research methodology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Tea Plant (Nutrients · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David StevensLiverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, L7 8TX, UK.
Deirdre A LaneLiverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, L7 8TX, UK. deirdre.lane@liverpool.ac.uk.
Stephanie L HarrisonLiverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, L7 8TX, UK.
Gregory Y H LipLiverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, L7 8TX, UK.
Ruwanthi Kolamunnage-DonaDepartment of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK.

Funding

Medical Research Council G0400615Medical Research Council MR/M013227/1
6 · The paper itself

Abstract

objectiveThe identification of methodology for modelling cardiovascular disease (CVD) risk using longitudinal data and risk factor trajectories.

methodsWe screened MEDLINE-Ovid from inception until 3 June 2020. MeSH and text search terms covered three areas: data type, modelling type and disease area including search terms such as "longitudinal", "trajector*" and "cardiovasc*" respectively. Studies were filtered to meet the following inclusion criteria: longitudinal individual patient data in adult patients with ≥3 time-points and a CVD or mortality outcome. Studies were screened and analyzed by one author. Any queries were discussed with the other authors. Comparisons were made between the methods identified looking at assumptions, flexibility and software availability.

resultsFrom the initial 2601 studies returned by the searches 80 studies were included. Four statistical approaches were identified for modelling the longitudinal data: 3 (4%) studies compared time points with simple statistical tests, 40 (50%) used single-stage approaches, such as including single time points or summary measures in survival models, 29 (36%) used two-stage approaches including an estimated longitudinal parameter in survival models, and 8 (10%) used joint models which modelled the longitudinal and survival data together. The proportion of CVD risk prediction models created using longitudinal data using two-stage and joint models increased over time.

conclusionsSingle stage models are still heavily utilized by many CVD risk prediction studies for modelling longitudinal data. Future studies should fully utilize available longitudinal data when analyzing CVD risk by employing two-stage and joint approaches which can often better utilize the available data.

Indexed as

Cardiovascular DiseasesHumansCardiovascular diseaseLongitudinalMethodological reviewRepeated measuresRisk prediction

Identifiers

PMID34922465
PMCPMC8684210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.